Jim Simons Tyra Biosciences, Inc. Transaction History

Renaissance Technologies LLC

  • $63.1 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
BUY
$11.61 - $20.0 $631,584 - $1.09 Million
54,400 New
54,400 $892,000
Q2 2022

Aug 12, 2022
SELL
$5.26 - $11.19 $154,118 - $327,867
-29,300 Closed
0 $0
Q1 2022

May 13, 2022
SELL
$10.03 - $14.09 $618,851 - $869,353
-61,700 Reduced 67.8%
29,300 $314,000
Q4 2021

Feb 11, 2022
BUY
$12.23 - $31.35 $1.11 Million - $2.85 Million
91,000 New
91,000 $1.28 Million

Others Institutions Holding TYRA

# of Institutions
98
Shares Held
43.5M
Call Options Held
353K
Put Options Held
1.1K
View Full List

About Tyra Biosciences, Inc.

TYRA Quotes by TradingView
  • Ticker TYRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,973,600
  • Market Cap $588M
  • Description
  • Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The comp...
More about TYRA
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email